| S. No | Intermediate Name | CAS No | API Name | Therapeutic Category | Status |
|---|---|---|---|---|---|
| 1 | 4-Amino-2,6-dichlorophenol | 5930-28-9 | Resmetirom | To treat noncirrhotic non-alcoholic steatohepatitis | In stock |
| 2 | 3,6-Dichloro-4-isopropylpyridazine | 107228-51-3 | Resmetirom | ||
| 3 | 6-(4-Amino-2,6-dichlorophenoxy)-4-isopropylpyridazin-3(2H)-one | 920509-28-0 | Resmetirom | ||
| 4 | Ethyl (2-cyanoacetyl)carbamate | 6629-04-05 | Resmetirom | ||
| 5 | (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester | 401564-36-1 | Teneligliptin | Diabetes | In stock |
| 6 | 2-Chloro-4-amino-6,7-dimethoxyquinazoline | 23680-84-4 | Alfuzosin/ Prazosin/ Doxazosin/ Terazosin |
Hypertension | In stock |
| 7 | 6-Chloro-4-(4-fluoro-2-methylphenyl)-N-methylpyridin-3-amine | 825643-62-7 | Elinzanetant | Hormonal treatment for moderate-to-severe vasomotor symptoms (VMS) associated with menopause | R&D quantities |
| 8 | 2-(3,5-Bis(trifluoromethyl) phenyl)-2-methylpropanoic acid | 289686-70-0 | Elinzanetant | R&D quantities | |
| 9 | (7S,9aS)-7-(((Tert-butyl dimethylsilyl)oxy)methyl) octa hydro pyrazino[2,1-c][1,4]oxazine | 929047-30-3 | Elinzanetant | R&D quantities |